Alcon has agreed to acquire struggling rival eyecare specialist STAAR Surgical in an equity deal valued at around $1.5bn.

BD has announced an investment exceeding $35m to expand the manufacturing of BD PosiFlush Prefilled Flush Syringes at its US facility.

The US FDA has conditionally approved TransMedics Group’s IDE to commence the next-generation OCS ENHANCE Heart study.

Regulatory and supply chain pressures place scaling medical device companies under strain. Expert partners can help ease these pain points.

To realise the potential of medical device data and maintain security protocols in a more connected medtech reality, network architecture must evolve.

Baxter’s share price declined by almost 23% on 31 July following the disclosure of disappointing Q2 2025 results that prompted the company to trim its 2025 profit outlook.

Trividia Health UK has launched the TRUEplus 5-Bevel Pen Needles in the country, marking the product's first entry outside the US.

Founder Juan José Chacón-Quiros discusses how Establishment Labs is transforming breast reconstruction and aesthetics with innovative, patient-focused solutions.

AI in the healthcare space has outpaced the rate of regulation, and without an update, HIPAA risks stifling innovation. The use of artificial intelligence (AI) and generative AI (GenAI) in the ...

Stryker has adjusted its 2025 profit outlook to between 9.5%-10%, up from 8.5%-9.5%, amid strong growth in its medical surgery and neurotechnology unit.

The FDA has approved SetPoint Medical’s neuroimmune modulation device, SetPoint System, to treat moderate-to-severe rheumatoid arthritis.

RFK Jr's statewide tour promoting his Make America Healthy Again (MAHA) agenda has been called “performative” by a US health consultancy.